Fund Holdings — Octagon Capital Advisors LP

Total Portfolio Value
$587.89M
Total Bought
$145.65M
Total Sold
$157.31M
Net Transaction
-$11.65M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
SCHOLAR ROCK HLDG CORP(SRRK)0488,000+488,000021,0913.59%+21,091
MERUS N V0308,000+308,000012,9512.20%+12,951
ERASCA INC(ERAS)05,136,795+5,136,795012,8932.19%+12,893
SYNDAX PHARMACEUTICALS INC(SNDX)0904,000+904,000011,9512.03%+11,951
KALVISTA PHARMACEUTICALS INC01,370,000+1,370,000011,6041.97%+11,604
APELLIS PHARMACEUTICALS INC
COM
3,006,9803,006,980086,72195,95316.32%+9,231
TAYSHA GENE THERAPIES INC(TSHA)4,572,22210,450,000+5,877,7789,19018,0793.08%+8,888
ARRIVENT BIOPHARMA INC(AVBP)1,976,3872,059,387+83,00046,44554,8629.33%+8,417
GOSSAMER BIO INC(GOSS)9,187,88318,350,000+9,162,1179,06316,5992.82%+7,536
COGENT BIOSCIENCES INC(COGT)1,305,0002,763,000+1,458,00014,09421,5513.67%+7,457
DYNE THERAPEUTICS INC(DYN)262,726668,000+405,2749,43715,7382.68%+6,301
NEUROGENE INC(NGNE)15,000303,000+288,0006296,9271.18%+6,297
ALLOVIR INC011,215,000+11,215,00004,7100.80%+4,710
UNICYCIVE THERAPEUTICS INC8,559,00010,000,000+1,441,0003,4917,9421.35%+4,451
MIND MEDICINE MINDMED INC3,018,0003,018,000017,17221,0053.57%+3,833
PHARVARIS N V
COM
620,470778,000+157,53011,49114,9142.54%+3,423
ATYR PHARMA INC0900,000+900,00003,2580.55%+3,258
CENTESSA PHARMACEUTICALS PLC2,012,0521,993,052-19,00032,17333,3845.68%+1,211
REGULUS THERAPEUTICS INC4,263,7014,848,802+585,1016,6947,6611.30%+967
NUVATION BIO INC(NUVB)312,336312,33607158310.14%+116
HELIX ACQUISITION CORP II250,000250,00002,6122,6250.45%+13
OCULAR THERAPEUTIX INC(OCUL)2,425,0002,425,000021,09820,7103.52%-388
MERSANA THERAPEUTICS INC992,000992,00001,8751,4190.24%-456
NKARTA INC(NKTX)120,0000-120,0005420—-542
RAPT THERAPEUTICS INC292,0000-292,0005870—-587
AUTOLUS THERAPEUTICS PLC(AUTL)176,0000-176,0006390—-639
AEROVATE THERAPEUTICS INC465,4400-465,4409730—-973
CENTURY THERAPEUTICS INC(IPSC)666,8250-666,8251,1400—-1,140
DIANTHUS THERAPEUTICS INC(DNTH)1,746,6672,110,167+363,50047,82446,0027.82%-1,822
BRIDGEBIO PHARMA INC(BBIO)552,000441,600-110,40014,05412,1182.06%-1,936
ANNEXON INC(ANNX)400,0000-400,0002,3680—-2,368
BLACK DIAMOND THERAPEUTICS I594,0000-594,0002,5840—-2,584
VIRIDIAN THERAPEUTICS INC(VRDN)870,000870,000019,79316,6782.84%-3,115
PEPGEN INC(PEPG)376,1170-376,1173,2160—-3,216
NUVATION BIO INC(NUVB)12,171,5139,202,907-2,968,60627,87324,4804.16%-3,393
RENEO PHARMACEUTICALS INC2,250,0000-2,250,0003,8250—-3,825
CYBIN INC(HELP)489,5960-489,5964,3530—-4,353
TENAYA THERAPEUTICS INC(TNYA)2,576,2000-2,576,2004,9720—-4,972
VENTYX BIOSCIENCES INC2,391,1140-2,391,1145,2130—-5,213
MINERALYS THERAPEUTICS INC(MLYS)600,0000-600,0007,2660—-7,266
PRAXIS PRECISION MEDICINES I(PRAX)130,0000-130,0007,4800—-7,480
EYEPOINT PHARMACEUTICALS INC(EYPT)1,093,5030-1,093,5038,7370—-8,737
INSMED INC(INSM)436,820332,000-104,82031,88822,9213.90%-8,967
ALLOVIR INC11,202,0000-11,202,0009,0570—-9,057
CORBUS PHARMACEUTICALS HLDGS(CRBP)1,115,0001,115,000023,00213,1572.24%-9,845
PERSPECTIVE THERAPEUTICS INC(CATX)1,422,2242,304,752+882,52818,9877,3521.25%-11,635
VERONA PHARMA PLC1,835,200571,264-1,263,93652,79926,5304.51%-26,269
STRUCTURE THERAPEUTICS INC1,198,0000-1,198,00052,5800—-52,580
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q4 2024 | TickerTrail